Skip to main content

Advertisement

Log in

Comparison of cytomorphology in specimens obtained by random periareolar fine needle aspiration and ductal lavage from women at high risk for development of breast cancer

  • Clinical trial
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Summary

Ductal lavage (DL) and random periareolar fine needle aspiration (RPFNA) are both being used to harvest epithelial cells for risk assessment as well as response evaluation in chemoprevention trials. The magnitude of increase in relative risk has been defined in a prospective study for RPFNA but not for DL atypia. We attempted both procedures in 26 women at high risk for development of breast cancer. Median age was 43 (range 32–57); 15 women were premenopausal, with 6 of the postmenopausal women on HRT. Collection of nipple aspirate fluid (NAF) was attempted and, if successful, was followed by DL; RPFNA was then performed on all women. Both procedures were attempted the same day (follicular phase of menstrual cycle if premenopausal) in 24 subjects and within three months for two subjects. Twenty-three subjects produced NAF, 17 of the 23 (74%) had a successful duct cannulation as part of the DL procedure, with 16 yielding sufficient ((10) ductal cells for morphologic assessment. Twenty-five of 26 (96%) subjects had a successful RPFNA procedure with adequate cellularity for morphology. There was concordance between DL and RPFNA specimens for traditional cytologic category assessment in 10/16 (63%), Masood index score in 13/16 (82%), and Consensus Panel assessment in 12/16 (75%) of specimens. We conclude that same day DL and RPFNA is feasible, with 62% and 96% of high-risk women having a successful procedure with evaluable cytomorphology. RPFNA was more likely to yield an evaluable specimen, but if a cellular DL specimen was obtained, morphology was generally similar.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Wellings SR, Jensen HM, Marcum RG, An atlas of subgross pathology of the human breast with special reference to possible precancerous lesionsJ Natl Cancer Inst 1975;55:231–273

    PubMed  CAS  Google Scholar 

  2. Boone CW, Bacus JW, Bacus JV, Steele VE, Kelloff GJ, Properties of intraepithelial neoplasia relevant to cancer chemoprevention and to the development of surrogate end points for clinical trialsProc Soc Exp Biol Med 1997;216:151–165

    PubMed  CAS  Google Scholar 

  3. Page DL, Dupont WD, Rogers LW, Rados MS, Atypical hyperplastic lesions of the female breast. A long-term follow-up studyCancer 1985;55:2698–2708

    Article  PubMed  CAS  Google Scholar 

  4. Page DL, Dupont WD, Anatomic markers of human premalignancy and risk of breast cancerCancer 1990; 66:1326–1335

    Article  PubMed  CAS  Google Scholar 

  5. Page DL, Kidd TE Jr, Dupont WD, Simpson JF, Rogers LW, Lobular neoplasia of the breast: higher risk for subsequent invasive cancer by more extensive diseaseHum Pathol 1991; 22:1232–1239

    Article  PubMed  CAS  Google Scholar 

  6. Tavassoli FA, Norris HJ, A comparison of the results of long-term followup for atypical intraductal hyperplasia and intraductal hyperplasia of the breastCancer 1990; 65:518–529

    Article  PubMed  CAS  Google Scholar 

  7. Ottesen GL, Graversen HP, Blichert-Toft M, Zedeler K, Andersen JA, Lobular carcinoma in situ of the female breast. Short-term results of a prospective nationwide study. The Danish Breast Cancer Cooperative GroupAm J Surg Pathol 1993;17:14–21

    Article  PubMed  CAS  Google Scholar 

  8. Modan B, Lubin F, Alfandary E, Chetrit A, Papa M, Breast cancer following benign breast disease – a nationwide study. Breast Cancer Res Treat 1997;46:45 (abstract 164)

    Google Scholar 

  9. Wrensch MR, Petrakis NL, Miike R, King EB, Chew K, Neuhaus J, Lee MM, Rhys M, Breast cancer risk in women with abnormal cytology in nipple aspirates of beast fluidJ Natl Cancer Inst 2001;93:1791–1798

    Article  PubMed  CAS  Google Scholar 

  10. Fabian CJ, Kimler BF, Zalles CM, Klemp JR, Kamel S, Zeiger S, Mayo MS, Short-term breast cancer prediction by random periareolar fine-needle aspiration cytology and the Gail risk modelJ Natl Cancer Inst 2000; 92:1217–1227

    Article  PubMed  CAS  Google Scholar 

  11. Wrensch M, Petrakis NL, King EB, Lee MM, Miike R, Breast cancer risk associated with abnormal cytology in nipple aspirates of breast fluid and prior history of breast biopsyAm J Epidemiol 1993;137:829–833

    PubMed  CAS  Google Scholar 

  12. Wrensch MR, Petrakis NL, King EB, Miike R, Mason L, Chew KL, Lee MM, Ernster VL, Hilton JF, Schweitzer R, Goodson WH III, Hunt TK, Breast cancer incidence in women with abnormal cytology in nipple aspirates of breast fluidAm J Epidemiol 1992;135:130–141

    PubMed  CAS  Google Scholar 

  13. Dooley WC, Ljung BM, Veronesi U, Cazzaniga M, Elledge RM, O’Shaughnessy JA, Kuerer HM, Hung DT, Khan SA, Phillips RF, Ganz PA, Euhus DM, Esserman LJ, Haffty BG, King BL, Kelley MC, Anderson MM, Schmit PJ, Clark RR, Kass FC, Anderson BO, Troyan SL, Arias RD, Quiring JN, Love SM, Page DL, King EB, Ductal lavage for detection of cellular atypia in women at high risk for breast cancerJ Natl Cancer Inst 2001;93:1624–1632

    PubMed  CAS  Google Scholar 

  14. Gail MH, Briton LA, Byar DP, Corle DK, Green SB, Schair C, Mulvihill JJ, Projecting individualized probabilities of developing breast cancer for white females who are being examined annuallyJ Natl Cancer Inst 1989; 81:1879–1886

    Article  PubMed  CAS  Google Scholar 

  15. Mayo MS, Kimler BF, Fabian CJ, Evaluation of models for the prediction of breast cancer development in women at high risk of breast cancerJ Appl Res 2001; 1:37–44

    Google Scholar 

  16. Morrow M, Vogel V, Ljung BM, O’Shaughnessy JA, Evaluation and management of the woman with an abnormal ductal lavageJ Am Coll Surg 2002;194:648–656

    Article  PubMed  Google Scholar 

  17. Vogel VG., Atypia in the assessment of breast cancer risk: implications for managementDiagn Cytopathol 2004; 30:151–157

    Article  PubMed  Google Scholar 

  18. Port ER, Montgomery LL, Heerdt AS, Borgen PI, Patient reluctance toward tamoxifen use for breast cancer primary preventionAnn Surg Oncol 2001;8:580–585

    Article  PubMed  CAS  Google Scholar 

  19. Tchou J, Hou N, Rademaker A, Jordan VC, Morrow M, Acceptance of tamoxifen chemoprevention by physicians and women at riskCancer 2004;100:1800–1806

    Article  PubMed  Google Scholar 

  20. Gail MH, Costantino JP, Bryant J, Croyle R, Freedman L, Helzlsouer K, Vogel V, Weighing the risks and benefits of tamoxifen treatment for preventing breast cancerJ Natl Cancer Inst 1999;91:1829–1846

    Article  PubMed  CAS  Google Scholar 

  21. Zalles C, Kimler BF, Kamel S, McKittrick R, Fabian CJ, Cytologic patterns in random aspirates from women at high and low risk for breast cancerThe Breast J 1995; 1:343–349

    Article  Google Scholar 

  22. The uniform approach to breast fine-needle aspiration biopsy. National Cancer Institute Fine-Needle Aspiration of Breast Workshop Subcommittees. Diagn Cytopathol 1997;16:295–311

    Article  Google Scholar 

  23. Ljung BM, Chew KL, Moore DH II, King EB, Cytology of ductal lavage fluid of the breastDiagn Cytopathol 2004;30:143–150

    Article  PubMed  Google Scholar 

  24. Masood S, Frykberg ER, McLellan GL, Scalapino MC, Mitchum DG, Bullard JB, Prospective evaluation of radiologically directed fine-needle aspiration biopsy of nonpalpable breast lesionsCancer 1990; 66:1480–1487

    Article  PubMed  CAS  Google Scholar 

  25. Visvanathan K, Santor D, Ali S, Brewster A, Arnold A, Armstrong D, Helzlsouer K The reliability of ductal lavage in women at high risk for breast cancer. Abstracts of the American Society of Clinical Oncology 2005 Annual Meeting; Abstract 1001

  26. Sharma P, Klemp JR, Simensen M, Welsko CM, Zalles CM, Kimler BF, Fabian CJ, Failure of high risk women to produce nipple aspirate fluid does not exclude detection of cytologic atypia in random periareolar fine needle aspiration specimensBreast Cancer Res Treat 2004;87:59–64

    Article  PubMed  Google Scholar 

  27. Khan SA, Wiley EL, Rodriguez N, Baird C, Ramakrishnan R, Nayar R, Bryk M, Bethke KB, Staradub VL, Wolfman J, Rademaker A, Ljung BM, Morrow M, Ductal lavage findings in women with known breast cancer undergoing mastectomyJ Natl Cancer Inst 2004;96:1510–1518

    Article  PubMed  Google Scholar 

  28. Cazzaniga M, Casadio C, Severi G, Chiapparini L, Galli A, Mora S, Veronesi U, Decensi A. Correlation between breast cancer risk, nipple discharge and atypical cells and KI-67 expression in ductal lavage specimens. American Association for Cancer Research Frontiers in Cancer Prevention Research 2003; p 33 (abstract A127)

  29. Love SM, King BL, Ductal lavage in nipple aspirate fluid producing and non-producing ducts in healthy volunteers Breast Cancer Res Treat 2004;88(Suppl 1):S189-S190(abstract 5019)

    Google Scholar 

  30. Wrensch MR, Petrakis NL, Gruenke LD, Ernster VL, Miike R, King EB, Hauck WW, Factors associated with obtaining nipple aspirate fluid: analysis of 1428 women and literature reviewBreast Cancer Res Treat 1990;15: 39–51

    Article  PubMed  CAS  Google Scholar 

  31. King EB, Chew KL, Hom JD, Miike R, Wrensch MR, Petrakis NL., Multiple sampling for increasing the diagnostic sensitivity of nipple aspirate fluid for atypical cytologyActa Cytol 2004;48:813–817

    PubMed  Google Scholar 

  32. Sauter ER, Ross E, Daly M, Klein-Szanto A, Engstrom PF, Sorling A, Malick J, Ehya H, Nipple aspirate fluid: a promising non-invasive method to identify cellular markers of breast cancer riskBr J Cancer 1997;76:494–501

    PubMed  CAS  Google Scholar 

  33. Francescatti DS, Kluskens L, Shah L, Ductal lavage using medically aseptic technique in women at high risk for breast cancerClin Breast Cancer 2004;5:299–302

    Article  PubMed  Google Scholar 

  34. Fabian CJ, Kimler BF, Elledge RM, Grizzle WE, Beenken SW, Ward JH, Models for early chemoprevention trials in breast cancerHematol Oncol Clin North Am 1998;12:993–1017

    Article  PubMed  CAS  Google Scholar 

  35. Fabian CJ, Kimler BF, Mayo MS, Grizzle WE, Masood, S, Ursin G: Clinical approaches to discovery and testing new breast cancer prevention drugs. In: Kelloff GJ, Hawk ET, Sigman CC (eds) Cancer Chemoprevention, Vol. 2; Strategies for Cancer Chemoprevention. Humana Press, Totowa, New Jersey, 2005, pp 213–238

  36. Fabian CJ, Kimler BF, Brady DA, Mayo MS, Chang CHJ, Ferraro JA, Zalles CM, Stanton AL, Masood S, Grizzle WE, Boyd NF, Arneson DW, Johnson KA, A phase II breast cancer chemoprevention trial of oral alpha-difluoromethylornithine: breast tissue, imaging, and serum and urine biomarkersClin Cancer Res 2002;8:3105–3117

    PubMed  CAS  Google Scholar 

Download references

Acknowledgement

Funded in part by contract CN-NO1-15135, from the Division of Cancer Prevention, NCI, NIH.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Carol J. Fabian.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zalles, C.M., Kimler, B.F., Simonsen, M. et al. Comparison of cytomorphology in specimens obtained by random periareolar fine needle aspiration and ductal lavage from women at high risk for development of breast cancer. Breast Cancer Res Treat 97, 191–197 (2006). https://doi.org/10.1007/s10549-005-9111-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-005-9111-x

Keywords

Navigation